My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Resolution 9521
MoundsView
>
Commissions
>
City Council
>
Resolutions
>
2020-2029
>
2021
>
Resolution 9521
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/28/2025 4:54:03 PM
Creation date
12/14/2021 11:01:32 AM
Metadata
Fields
Template:
MV Commission Documents
Commission Name
City Council
Commission Doc Type
Resolutions
MEETINGDATE
12/13/2021
Commission Doc Number (Ord & Res)
9521
Supplemental fields
City Council Document Type
Resolutions
Date
12/13/2021
Resolution/Ordinance Number
9521
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
33
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
MINNESOTA OPIOIDS STATE -SUBDIVISION MEMORANDUM OF AGREEMENT <br />WHEREAS, the State of Minnesota, Minnesota counties and cities, and their people have been <br />harmed by misconduct committed by certain entities that engage in or have engaged in the <br />manufacture, marketing, promotion, distribution, or dispensing of an opioid analgesic; <br />WHEREAS, certain Minnesota counties and cities, through their counsel, and the State, through <br />its Attorney General, are separately engaged in ongoing investigations, litigation, and settlement <br />discussions seeking to hold opioid manufacturers and distributors accountable for the damage <br />caused by their misconduct; <br />WHEREAS, the State and Local Governments share a common desire to abate and alleviate the <br />impacts of the misconduct described above throughout Minnesota; <br />WHEREAS, while the State and Local Governments recognize the sums which may be available <br />from the aforementioned litigation will likely be insufficient to fully abate the public health crisis <br />caused by the opioid epidemic, they share a common interest in dedicating the most resources <br />possible to the abatement effort; <br />WHEREAS, the investigations and litigation with Johnson & Johnson, AmerisourceBergen, <br />Cardinal Health, and McKesson have resulted in National Settlement Agreements with those <br />companies, which the State has already committed to join; <br />WHEREAS, Minnesota's share of settlement funds from the National Settlement Agreements will <br />be maximized only if all Minnesota counties, and cities of a certain size, participate in the <br />settlements; <br />WHEREAS, the National Settlement Agreements will set a default allocation between each state <br />and its political subdivisions unless they enter into a state -specific agreement regarding the <br />distribution and use of settlement amounts; <br />WHEREAS, this Memorandum of Agreement is intended to facilitate compliance by the State <br />and by the Local Governments with the terms of the National Settlement Agreements and is <br />intended to serve as a State -Subdivision Agreement under the National Settlement Agreements; <br />WHEREAS, this Memorandum of Agreement is also intended to serve as a State -Subdivision <br />Agreement under resolutions of claims concerning alleged misconduct in the manufacture, <br />marketing, promotion, distribution, or dispensing of an opioid analgesic entered in bankruptcy <br />court that provide for payments (including payments through a trust) to both the State and <br />Minnesota counties and cities and allow for the allocation between a state and its political <br />subdivisions to be set through a state -specific agreement; and <br />WHEREAS, specifically, this Memorandum of Agreement is intended to serve under the <br />Bankruptcy Resolutions concerning Purdue Pharma and Mallinckrodt as a qualifying Statewide <br />Abatement Agreement. <br />1 <br />
The URL can be used to link to this page
Your browser does not support the video tag.